These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 21269566)
1. Wilms' tumor protein and FLT3-internal tandem duplication expression in patients with de novo acute myeloid leukemia. Spassov BV; Stoimenov AS; Balatzenko GN; Genova ML; Peichev DB; Konstantinov SM Hematology; 2011 Jan; 16(1):37-42. PubMed ID: 21269566 [TBL] [Abstract][Full Text] [Related]
2. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance]. Wang YG; Liu XH; Liang Y; Jin J Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010 [TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia. Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation. Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790 [TBL] [Abstract][Full Text] [Related]
5. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group. Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059 [TBL] [Abstract][Full Text] [Related]
6. High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in Sharawat SK; Raina V; Kumar L; Sharma A; Bakhshi R; Vishnubhatla S; Gupta R; Bakhshi S Indian J Med Res; 2016 May; 143(Supplement):S11-S16. PubMed ID: 27748272 [TBL] [Abstract][Full Text] [Related]
7. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway. Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110 [TBL] [Abstract][Full Text] [Related]
8. Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia. Abdelhamid E; Preudhomme C; Helevaut N; Nibourel O; Gardin C; Rousselot P; Castaigne S; Gruson B; Berthon C; Soua Z; Renneville A Leuk Res; 2012 Mar; 36(3):316-23. PubMed ID: 22129478 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3. Mehta SV; Shukla SN; Vora HH Neoplasma; 2013; 60(6):666-75. PubMed ID: 23906301 [TBL] [Abstract][Full Text] [Related]
10. [Correlation of Fms-like tyrosine kinase 3 (FLT3) gene expression to FLT3/internal tandem duplication mutation in peripheral blood of acute myeloid leukemia.]. Xu B; Shi PC; Song XY; Tang JH; Zhou SY Ai Zheng; 2009 Jun; 28(6):632-6. PubMed ID: 19635202 [TBL] [Abstract][Full Text] [Related]
11. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943 [TBL] [Abstract][Full Text] [Related]
12. FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia. Zhong L; Jia YQ; Meng WT; Ni X Arch Pathol Lab Med; 2012 Jan; 136(1):84-9. PubMed ID: 22208491 [TBL] [Abstract][Full Text] [Related]
13. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862 [TBL] [Abstract][Full Text] [Related]
14. NFATc1 as a therapeutic target in FLT3-ITD-positive AML. Metzelder SK; Michel C; von Bonin M; Rehberger M; Hessmann E; Inselmann S; Solovey M; Wang Y; Sohlbach K; Brendel C; Stiewe T; Charles J; Ten Haaf A; Ellenrieder V; Neubauer A; Gattenlöhner S; Bornhäuser M; Burchert A Leukemia; 2015 Jul; 29(7):1470-7. PubMed ID: 25976987 [TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. Paschka P; Marcucci G; Ruppert AS; Whitman SP; Mrózek K; Maharry K; Langer C; Baldus CD; Zhao W; Powell BL; Baer MR; Carroll AJ; Caligiuri MA; Kolitz JE; Larson RA; Bloomfield CD J Clin Oncol; 2008 Oct; 26(28):4595-602. PubMed ID: 18559874 [TBL] [Abstract][Full Text] [Related]
16. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Sengsayadeth SM; Jagasia M; Engelhardt BG; Kassim A; Strickland SA; Goodman S; Lucid C; Vnencak-Jones CL; Greer JP; Savani BN Bone Marrow Transplant; 2012 Dec; 47(12):1535-7. PubMed ID: 22659680 [TBL] [Abstract][Full Text] [Related]
17. Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis. Brunet S; Labopin M; Esteve J; Cornelissen J; Socié G; Iori AP; Verdonck LF; Volin L; Gratwohl A; Sierra J; Mohty M; Rocha V J Clin Oncol; 2012 Mar; 30(7):735-41. PubMed ID: 22291086 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia. Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Chang WH Cancer; 2002 Jun; 94(12):3292-8. PubMed ID: 12115363 [TBL] [Abstract][Full Text] [Related]
19. [FLT3 mutations in children with acute myeloid leukemia: a single center study]. Ruan M; Wang YQ; Zhang L; Liu TF; Liu F; Liu XM; Zhang JY; Zou Y; Chen YM; Zhu XF Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):863-6. PubMed ID: 22099191 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of Wilms tumor 1 gene as a negative prognostic indicator in acute myeloid leukemia. Lyu X; Xin Y; Mi R; Ding J; Wang X; Hu J; Fan R; Wei X; Song Y; Zhao RY PLoS One; 2014; 9(3):e92470. PubMed ID: 24667279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]